GlassScriptPhysician profile
Adam Bruggeman
NPI 1316160625
$64,081.03
in general payments reported to CMS, 2019-2025
33 companies · $2,830 in 2025
The $2,830 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $25K · 2021: $2,749 · 2022: $1,658 · 2023: $1,381 · 2024: $2,156 · 2025: $2,830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,410 · Travel and Lodging: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,410.44 |
| Travel and Lodging | $956.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $16,643.11 | 2019-2025 | Monterey Al, Optablate |
| Titan Spine, LLC | $16,642.48 | 2019 | |
| Medtronic USA, INC. | $12,545.92 | 2019-2020 | |
| Si-Bone, INC. | $7,806.66 | 2019-2025 | |
| Intrinsic Therapeutics | $4,055.24 | 2023-2025 | Barricaid Acd (Annular Closure Device) |
| Abbott Laboratories | $1,134.73 | 2019-2024 | Eterna, Proclaim, Octrode |
| Centinel Spine, LLC | $1,063.33 | 2019-2025 | Prodisc L, Prodisc C Vivo |
| Boston Scientific Corporation | $862.45 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Clinical Trial Product |
| Curiteva, INC. | $666.59 | 2020-2025 | |
| Alafair Biosciences, INC. | $461.85 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $240.54 | 2019-2021 | |
| Medtronic, INC. | $224.70 | 2022-2023 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $171.01 | 2022-2025 | Cervical-Stim, Spinal-Stim, Physio-Stim |
| Spineart USA INC | $157.06 | 2022 | |
| Clariance, INC. | $150.89 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $136.61 | 2022 | |
| Neo Spine USA, INC. | $118.71 | 2019 | |
| Nexxt Spine LLC | $115.88 | 2020 | |
| Integrity Implants INC. Dba Accelus | $109.70 | 2024 | |
| Pacira Therapeutics, INC. | $103.47 | 2021 | |
| Painteq LLC | $94.70 | 2024 | Painteq |
| Smith+Nephew, INC. | $87.75 | 2019 | |
| Life Spine, INC. | $82.75 | 2023 | Simpact, Prolift, Dyna-Link Stand-Alone Anterior Lumbar System |
| Globus Medical, INC. | $77.45 | 2023 | Creo 5.5 |
| Vb Spine LLC | $68.40 | 2025 | Monterey Al |
| Pacira Pharmaceuticals Incorporated | $65.21 | 2022 | |
| Nevro Corp. | $56.49 | 2023-2024 | Senza |
| Ets Wound Care LLC | $29.22 | 2023 | Mirragen Advanced Wound Matrix |
| Depuy Synthes Sales INC. | $28.72 | 2019 | |
| Biocomposites INC | $23.40 | 2021 | |
| Baxter Healthcare | $19.87 | 2024 | Floseal |
| Djo, LLC | $18.16 | 2020 | |
| Medacta USA, INC. | $17.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Bruggeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.